Shareholders holding 5% or more votes at Annual General Meeting of 28 May 2025

Date: 28 May 2025

Subject: Shareholders holding 5% or more votes at Annual General Meeting of 28 May 2025

Legal basis: Article 70(3) of the Public Offering Act – Shareholders holding 5% or more of total voting rights at General Meeting

The Management Board of Diagnostyka S.A. of Kraków (the “Company”) announces that at the Annual General Meeting of the Company convened for 28 May 2025 the shareholders holding 5% or more of the total vote were as follows:

• Jakub Swadźba, who held voting rights from 3,186,189 shares, entitling him to 6,372,378 votes, representing approximately 15.29% of the votes present at the Annual General Meeting and 12.82% of the total number of votes;
• ACER CAPITAL PARTNERS SCSP, which held voting rights from 6,372,278 shares, entitling it to 12,744,556 votes, representing approximately 30.58% of the votes present at the Annual General Meeting and 25.65% of the total number of votes;
• ACACIA CAPITAL PARTNERS SCSP, which held voting rights from 6,372,278 shares, entitling it to 12,744,556 votes, representing approximately 30.58% of the votes present at the Annual General Meeting and 25.65% of the total number of votes.

For the Company:

Jakub Swadźba – CEO, President of the Management Board

Paweł Chytła – Vice President of the Management Board